About Us

COMPANY PROFILE

         Changzhou Xinli New Material Co., Ltd. is a company based on chemical science, dedicated to the licensed production of medicines, pesticides and organic chemical materials, and provides research and development customization for domestic and abrod company serving.  we always provide custome···


News

THE LATEST NEWS

全新止痛机制,Vertex公司离子通道抑制剂获得2期临床概念验证

今日,Vertex Pharmaceuticals公司宣布,其在研选择性NaV1.8通道抑制剂VX-548...

01

01

全新止痛机制,Vertex公司离子通道抑制剂获得2期临床概念验证

今日,Vertex Pharmaceuticals公司宣布,其在研选择性NaV1.8通道抑制剂VX-548...

01

01

帮助选择最可能从免疫疗法获益的非小细胞肺癌患者,微RNA血检结果发表

今日,Hummingbird Diagnostics公司宣布,其基于微RNA(miRNA)生物标志物特征的血液检测miRisk的发现和验证研究,在科学期刊npj Precision Oncology上发表。...

31

31

速递 | 治疗免疫检查点抑制剂难治性非小细胞肺癌,LAG-3疗法2期临床结果积极

今日,Immutep公司宣布,其LAG-3融合蛋白eftilagimod alpha(efti,又名IMP321),与默沙东(MSD)公司的重磅PD-1抑制剂Keytruda联用,在二线治疗转移性非小细胞肺癌患者的2期临床试验中获得积极中期数据。...

Copyright © Junyu Chemexpress Co., Ltd., All Rights Reserved